These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29326482)

  • 1. Compounded Apixaban Suspensions for Enteral Feeding Tubes.
    Caraballo ML; Donmez S; Nathan K; Zhao F
    Hosp Pharm; 2017 Jul; 52(7):478-482. PubMed ID: 29326482
    [No Abstract]   [Full Text] [Related]  

  • 2. In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.
    Reindel K; Zhao F; Hughes S; Dave VS
    Hosp Pharm; 2017 Dec; 52(11):752-760. PubMed ID: 29276255
    [No Abstract]   [Full Text] [Related]  

  • 3. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
    Zhao F; Dave VS; Mar MZ; Perri JR
    Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of extemporaneously prepared rufinamide oral suspensions.
    Hutchinson DJ; Liou Y; Best R; Zhao F
    Ann Pharmacother; 2010 Mar; 44(3):462-5. PubMed ID: 20150505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounding rifampin suspensions with improved injectability for nasogastric enteral feeding tube administration.
    de Villiers MM; Vogel L; Bogenschutz MC; Fingerhut BJ; D'Silva JB; Moore A
    Int J Pharm Compd; 2010; 14(3):250-6. PubMed ID: 23965503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The stability of quetiapine oral suspension compounded from commercially available tablets.
    Tran J; Gervase MA; Evans J; Deville R; Dong X
    PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
    Zhang YP; Trissel LA; Fox JL
    Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Assessment for Dose Preparation and Simulated Administration of Azithromycin Suspensions via Enteral Feeding Tubes.
    Santangelo M; Wood JA; Barnett KL; Wooding FGG; Bartlett JA
    Hosp Pharm; 2022 Apr; 57(2):260-267. PubMed ID: 35601710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
    Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
    Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of crushed ticagrelor tablet doses: recovery following crushing and naso-gastric tube passage ex vivo.
    Crean B; Finnie C; Crosby A
    Drugs R D; 2013 Jun; 13(2):153-7. PubMed ID: 23737454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability and Beyond-Use Date of a Compounded Thioguanine Suspension.
    Gilda SS; Kolling WM; Nieto M; McPherson T
    J Pharm Technol; 2021 Feb; 37(1):23-29. PubMed ID: 34752544
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date.
    Peacock GF; Sauvageot J; Hill A; Killian A
    Int J Pharm Compd; 2016; 20(1):81-5. PubMed ID: 27125058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of sotalol hydrochloride in extemporaneously prepared oral suspension formulations.
    Sidhom MB; Rivera N; Almoazen H; Taft DR; Kirschenbaum HL
    Int J Pharm Compd; 2005; 9(5):402-6. PubMed ID: 23925139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days.
    Svirskis D; Jaffer J; Agarwal P; Khan A; Kaur J; Cheng A; Hanning S
    Int J Pharm Compd; 2020; 24(3):246-251. PubMed ID: 32401745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of cilazapril in pediatric oral suspensions prepared from commercially available tablet dosage forms.
    Stanisz BJ; Paszun SK; Zalewska A
    Acta Pol Pharm; 2014; 71(4):661-6. PubMed ID: 25272892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium canrenoate compounding for administration via enteral feeding tubes: a physical and microbiological stability study.
    Logrippo S; Sestili M; Ganzetti R; Bonacucina G; Marziali A; Fattoretti P; Busco S; Caraffa A; Polidori C; Palmieri GF
    Eur J Hosp Pharm; 2018 Oct; 25(e2):e120-e125. PubMed ID: 31157081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.